1887

Journal of Medical Microbiology logo

Volume 56, Issue 11

Evaluation of the ability of erythromycin-resistant and -susceptible pharyngeal group A isolates from Spain to enter and persist in human keratinocytes Free

Abstract

The macrolide-resistance rate among group A (GAS) isolates has increased in some European countries. To investigate the reasons for this increase, the ability of 60 erythromycin-resistant and 61 erythromycin-susceptible, genetically unrelated, pharyngeal GAS isolates from Spain to enter and persist within human keratinocytes was evaluated. It was observed that erythromycin resistance was associated with the presence of , a gene related to invasiveness, whereas no association was observed with the ability to enter human keratinocytes. However, the ability to enter human keratinocytes was not associated with the presence of or with the type, suggesting that interaction with keratinocytes depends on several characteristics of the isolate. Almost all strains (95.9 %) were capable of persisting within human keratinocytes. However, most of them (91.7 %) exhibited a decline in viability over time. Interestingly, the ability to persist within keratinocytes protected from the action of the -lactams was higher among erythromycin-resistant isolates and correlated with their ability to avoid the induction of cellular lysis. These observations suggest that if the carrier state results from intracellular GAS survival, the association between erythromycin resistance and intracellular persistence may represent a serious problem for the eradication of these isolates.

  • Received:
  • Accepted:
  • Published Online:
Keyword(s): GAS, group A Streptococcus
SGM
Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.47203-0
2007-11-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jmm/56/11/1485.html?itemId=/content/journal/jmm/10.1099/jmm.0.47203-0&mimeType=html&fmt=ahah

References

  1. Albertí S., García-Rey C., Domínguez M. A., Aguilar L., Cercenado E., Gobernado M., García-Perea A. Spanish Surveillance Group for Respiratory Pathogens 2003; Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. J Clin Microbiol 41:2385–2390 [CrossRef]
     [Google Scholar]
  2. Ashbaugh C. D., Moser T. J., Shearer M. H., White G. L., Kennedy R. C., Wessels M. R. 2000; Bacterial determinants of persistent throat colonization and the associated immune response in a primate model of human group A streptococcal pharyngeal infection. Cell Microbiol 2:283–292 [CrossRef]
     [Google Scholar]
  3. Beckert S., Kreikemeyes B., Podbielski A. 2001; The group A streptococcal rofA gene is involved in the control of several virulence genes and eukaryotic cell attachment and internalization. Infect Immun 69:534–537 [CrossRef]
     [Google Scholar]
  4. Bingen E., Bidet P., Mihaila-Amrouche L., Doit C., Forcet S., Brahimi N., Bouvet A., Cohen R. 2004; Emergence of macrolide-resistant Streptococcus pyogenes strains in French children. Antimicrob Agents Chemother 48:3559–3562 [CrossRef]
     [Google Scholar]
  5. Cocuzza C. E., Lanzafame A., Sisto F., Broccolo F., Mattina R. 2004; Prevalence of the internalization-associated gene prtF1 in a bacterial population of Streptococcus pyogenes isolated from children with acute pharyngotonsillitis before and after antibiotic therapy. Microb Drug Resist 10:264–268 [CrossRef]
     [Google Scholar]
  6. Courtney H. S., Hasty D. L., Dale J. B. 2002; Molecular mechanisms of adhesion, colonization and invasion of group A streptococci. Ann Med 34:77–87 [CrossRef]
     [Google Scholar]
  7. Cywes C., Wessels M. R. 2001; Group A streptococcus tissue invasion by CD44-mediated cell signalling. Nature 414:648–652 [CrossRef]
     [Google Scholar]
  8. Dicuonzo G., Fiscarelli E., Gherardi G., Lorino G., Battistoni F., Landi S., De Cesaris M., Petitti T., Beall B. 2002; Erythromycin-resistant pharyngeal isolates of Streptococcus pyogenes recovered in Italy. Antimicrob Agents Chemother 46:3987–3990 [CrossRef]
     [Google Scholar]
  9. Facinelli B., Spinaci C., Magi G., Giovanetti E., Varaldo P. E. 2001; Association between erythromycin resistance and ability to enter human respiratory cells in group A streptococci. Lancet 358:30–33 [CrossRef]
     [Google Scholar]
  10. García-Rey C., Aguilar L., Baquero F., Casal J., Martin J. E. 2002; Pharmacoepidemiological analysis of provincial differences between consumption of macrolides and rates of erythromycin resistance among Streptococcus pyogenes isolates in Spain. J Clin Microbiol 40:2959–2963 [CrossRef]
     [Google Scholar]
  11. Haller M., Fluegge K., Arri A. J., Adams B., Berner R. 2005; Association between resistance to erythromycin and the presence of the fibronectin binding protein F1 gene, prtF1 , in Streptococcus pyogenes isolates from German pediatric patients. Antimicrob Agents Chemother 49:2990–2993 [CrossRef]
     [Google Scholar]
  12. Kaplan E. L., Chhatwal G. S., Rohde M. 2006; Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications. Clin Infect Dis 43:1398–1406 [CrossRef]
     [Google Scholar]
  13. Leclercq R. 2002; Mechanisms of resistance to macrolides and lincosamides: nature of the resistance elements and their clinical implications. Clin Infect Dis 34:482–492 [CrossRef]
     [Google Scholar]
  14. Melo-Cristino J., Fernandes M. L. 1999; Streptococcus pyogenes isolated in Portugal: macrolide resistance phenotypes and correlation with T types. Microb Drug Resist 5:219–225 [CrossRef]
     [Google Scholar]
  15. Molinari G., Chhatwal G. S. 1998; Invasion and survival of Streptococcus pyogenes in eukaryotic cells correlates with the source of the clinical isolates. J Infect Dis 177:1600–1607 [CrossRef]
     [Google Scholar]
  16. Molinari G., Talay S. R., Valentin-Weigand P., Rohde M., Chhatwal G. S. 1997; The fibronectin-binding protein of Streptococcus pyogenes , SfbI, is involved in the internalization of group A streptococci by epithelial cells. Infect Immun 65:1357–1363
     [Google Scholar]
  17. Molinari G., Rohde M., Talay S. R., Chhatwal G. S., Beckert S., Podbielski A. 2001; The role played by the group A streptococcal negative regulator Nra on bacterial interactions with epithelial cells. Mol Microbiol 40:99–114 [CrossRef]
     [Google Scholar]
  18. NCCLS Standard 2000 Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically , 5th edn. Approved. NCCLS document M7-45 Wayne, PA: National Committee for Clinical Laboratory Standards;
     [Google Scholar]
  19. Neeman R., Keler N., Barzilai A., Korenman Z., Sela S. 1998; Prevalence of internalisation-gene, prtF1 , among group-A streptococcus strains isolated from asymptomatic carriers. Lancet 352:1974–1977 [CrossRef]
     [Google Scholar]
  20. Ozeri V., Rosenshine I., Mosher D. F., Fassler R., Hanski E. 1998; Roles of integrins and fibronectin in the entry of Streptococcus pyogenes into cells via protein F1. Mol Microbiol 30:625–637 [CrossRef]
     [Google Scholar]
  21. Pérez-Trallero E., García-de-la-Fuente C., García-Rey C., Baquero F., Aguilar L., Dal-Ré R., García-de-Lomas J. Spanish Surveillance Group for Respiratory Pathogens 2005; Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain. Antimicrob Agents Chemother 49:1965–1972 [CrossRef]
     [Google Scholar]
  22. Schrager H. M., Rheinwald J. G., Wessels M. R. 1996; Hyaluronic acid capsule and the role of streptococcal entry into keratinocytes in invasive skin infection. J Clin Invest 98:1954–1958 [CrossRef]
     [Google Scholar]
  23. Schrager H. M., Albertí S., Cywes C., Dougherty G. J., Wessels M. R. 1998; Hyaluronic acid capsule modulates M-protein mediated adherence and acts as a ligand for attachment of group A Streptococcus to CD44 on human keratinocytes. J Clin Invest 101:1708–1716 [CrossRef]
     [Google Scholar]
  24. Seppala H., Nissinen A., Yu Q., Huovinen P. 1993; Three different phenotypes of erythromycin-resistant Streptococcus pyogenes in Finland. J Antimicrob Chemother 32:885–891 [CrossRef]
     [Google Scholar]
  25. Seppala H., Skurnik M., Soini H., Roberts M. C., Huovinen P. 1998; A novel erythromycin resistance methylase gene ( ermTR ) in Streptococcus pyogenes . Antimicrob Agents Chemother 42:257–262 [CrossRef]
     [Google Scholar]
  26. Spinaci C., Magi G., Zampaloni C., Vitali L. A., Paoletti C., Catania M. R., Prenna M., Ferrante L., Ripa S. other authors 2004; Genetic diversity of cell-invasive erythromycin-resistant and -susceptible group A streptococci determined by analysis of the RD2 region of the prtF1 gene. J Clin Microbiol 42:639–644 [CrossRef]
     [Google Scholar]
  27. Spinaci C., Magi G. E. V. P., Facinelli B. 2006; Persistence of erythromycin-resistant group A streptococci in cultured respiratory cells. Pediatr Infect Dis J 25:880–883 [CrossRef]
     [Google Scholar]
  28. Sutcliffe J., Grebe T., Tait-Kamradt A., Wondrack L. 1996; Detection of erythromycin-resistant determinants by PCR. Antimicrob Agents Chemother 40:2562–2566
     [Google Scholar]
  29. Tsai P.-J., Lin Y.-S., Kuo C.-F., Lei H.-Y., Wu J.-J. 1999; Group A streptococcus induces apoptosis in human epithelial cells. Infect Immun 67:4334–4339
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.47203-0
Loading
Evaluation of the ability of erythromycin-resistant and -susceptible pharyngeal group A Streptococcus isolates from Spain to enter and persist in human keratinocytes
J. Med. Microbiol. 56, 1485 (2007); https://doi.org/10.1099/jmm.0.47203-0
/content/journal/jmm/10.1099/jmm.0.47203-0
/content/journal/jmm/10.1099/jmm.0.47203-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error